Disclosures of payments made to HCPs

We acknowledge the importance of increased transparency and of putting the patient at the centre of every decision we take. We remain committed to disclosing the payments we make to HCPs and intend to expand our reporting of payments to individual HCPs.

We already publish payments made to HCPs in 32 markets across Europe (including Russia and Ukraine) as well as Australia, Japan and the US for activities such as advisory boards, scientific symposiums and market research.

From 2019, where legally permitted, we will now report individual level payments made each year to HCPs for attending educational meetings and for the provision of services, such as speaking at events or attending advisory boards. Where individual level disclosure is not legally permitted, we will continue to report aggregate payments.

Find out more about our payments to HCPs in the USAEurope and the rest of the world on gsk.com.